Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check3 days agoChange DetectedA newer release version label (Revision: v3.5.4) appears, replacing the previous v3.5.3, indicating an update to the page's release notes.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.5.3 was added to the record history and the previous entry v3.5.2 was removed, updating the documented version history on the page. This reflects an archival update to the page's release history.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.5.2 was added to the record history and the v3.5.0 entry was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedNew screenshot shows minor visual/layout adjustments to the Record History page; substantive study data and sections remain unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedA new history version (v39, 2026-03-26) with a Study Status update was added; the 2025-08-06 entry was removed.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision history now includes v3.5.0 as an addition and v3.4.3 as a deletion.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.